Skip to content

Selegiline

Monoamine Oxidase Inhibitor — NERVOUS SYSTEM

Also known as: (-)-deprenil, (-)-deprenyl, (-)-selegiline, (r)-(-)-deprenyl, (r)-selegiline, anipryl, l-deprenyl, selegiline HCl, selegiline hydrochloride, selegina, selgene, zelapar

OfpFDA approvedOrphan designationATC N04BD01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Selegiline is an ofp drug in the Monoamine Oxidase Inhibitor class catalogued in DrugCentral. It was first approved by the FDA in 1989. Its mechanism of action is classified as Monoamine Oxidase Inhibitors and Monoamine Oxidase-B Inhibitors. DrugCentral lists 10 molecular targets, including Maob|Maoa, MAOB and ADRA2B. Recorded indications include Major depressive disorder and Parkinson's disease.

  • Approval status: ofp (first approved 1989 by the FDA).
  • Drug class: Monoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor.
  • Mechanism of action: Monoamine Oxidase Inhibitors; Monoamine Oxidase-B Inhibitors.
  • Molecular targets: Maob|Maoa, MAOB, ADRA2B and SNCA (10 listed in DrugCentral).
  • Indications: Major depressive disorder and Parkinson's disease.
  • ATC code: N04BD01 (Monoamine oxidase B inhibitors).
  • Molecular formula: C13H17N; molecular weight 187.29 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Major depressive disorder
  • Parkinson's disease

Contraindications (12)

  • Angina pectoris
  • Bipolar disorder
  • Conduction disorder of the heart
  • Disease of liver
  • Kidney disease
  • Malignant melanoma
  • Mania
  • Orthostatic hypotension
  • Pheochromocytoma
  • Psychotic disorder
  • Suicidal thoughts
  • Tardive dyskinesia

Mechanism & targets

Mechanism of action (MoA)Monoamine Oxidase Inhibitors; Monoamine Oxidase-B Inhibitors
Established pharmacologic classMonoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor

Molecular targets (10)

TargetGeneActionActivity
Monoamine oxidaseMaob|MaoaunknownIC50 7.89
Amine oxidase [flavin-containing] BMAOBinhibitorKi 7.26
Alpha-2B adrenergic receptorADRA2BunknownKi 6.76
Alpha-synucleinSNCAunknownIC50 6.57
Alpha-2A adrenergic receptorADRA2AunknownKi 6.17
Amine oxidase [flavin-containing] BMAOBunknownKi 6.01
Amine oxidase [flavin-containing] BMaobunknownKi 5.87
Amine oxidase [flavin-containing] AMAOAunknownKi 5.42
Amine oxidase [flavin-containing] AMAOAunknownKi 5.04
Amine oxidase [flavin-containing] AMaoaunknownKi 4.98

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1989-06-05FDA—SOMERSETYes

ATC classification

ATC codeTherapeutic hierarchy
N04BD01NERVOUS SYSTEM › ANTI-PARKINSON DRUGS › DOPAMINERGIC AGENTS › Monoamine oxidase B inhibitors

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Hallucination335.8
Dyskinesia316.7
Parkinsonism hyperpyrexia syndrome308.8
Application site rash257.2
Application site erythema209.4
Hallucination, visual190.9
Drug interaction134.3
Impulse-control disorder129.2
Application site pruritus122.6
Application site reaction118.4
On and off phenomenon117.1
Hypersexuality106.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Selegiline is on its molecule page.

Molecular formulaC13H17N
Molecular weight187.29 g/mol
CAS number14611-51-9
InChIKeyMEZLKOACVSPNER-GFCCVEGCSA-N
PubChem CID26757
C[C@H](CC1=CC=CC=C1)N(C)CC#C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Selegiline used for?

DrugCentral lists the following indications for Selegiline: Major depressive disorder and Parkinson's disease.

How does Selegiline work?

Selegiline is classified as Monoamine Oxidase Inhibitors and Monoamine Oxidase-B Inhibitors; its molecular targets in DrugCentral include Maob|Maoa, MAOB (inhibitor), ADRA2B and SNCA.

When was Selegiline first approved?

Selegiline was first approved by the FDA in 1989.

What drug class does Selegiline belong to?

Selegiline is in the Monoamine Oxidase Inhibitor class.

What is the chemical formula of Selegiline?

Selegiline has the molecular formula C13H17N and a molecular weight of 187.29 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1989-06-05
AgencyFDA
Targets10
Indications2
FormulaC13H17N
DrugCentral ID2429
Interactive profile